Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension

Publisher： Karger

E-ISSN： 1423-0356|94|3|263-271

ISSN： 0025-7931

Source： Respiration, Vol.94, Iss.3, 2017-08, pp. : 263-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Urodynamic Efficacy and Safety of Mirabegron Add‐on Treatment with Tamsulosin for Japanese Male Patients with Overactive Bladder

By  

LUTS, Vol. 8, Iss. 3, 2016-09 ,pp. : 171-176

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy, safety, and pharmacokinetics of ambrisentan in Japanese adults with pulmonary arterial hypertension

By Yoshida Shunji   Shirato Kunio   Shimamura Ryutaro   Nakahara Norie   Iwase Takayuki   Nakajima Hiromu  

Current Medical Research and Opinion, Vol. 27, Iss. 9, 2011-09 ,pp. : 1827-1834

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Long-Term Imatinib Therapy for Pulmonary Arterial Hypertension

By  

Respiration, Vol. 89, Iss. 6, 2015-06 ,pp. : 515-524

Karger

Access to resources Recommend Favorite

Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation

By  

Respiration, Vol. 91, Iss. 1, 2016-0 ,pp. : 9-17

Karger

Access to resources Recommend Favorite

Spleen Size in Idiopathic and Heritable Pulmonary Arterial Hypertension

By  

Respiration, Vol. 85, Iss. 5, 2012-08 ,pp. : 391-399

Karger

Access to resources Recommend Favorite